Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1998 1
2002 1
2005 6
2006 3
2007 4
2008 2
2009 6
2010 8
2011 9
2012 8
2013 4
2014 6
2015 15
2016 16
2017 18
2018 15
2019 19
2020 31
2021 24
2022 27
2023 19
2024 14
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Cognitive Dysfunction in Cancer Survivors.
Országhová Z, Mego M, Chovanec M. Országhová Z, et al. Among authors: mego m. Front Mol Biosci. 2021 Dec 14;8:770413. doi: 10.3389/fmolb.2021.770413. eCollection 2021. Front Mol Biosci. 2021. PMID: 34970595 Free PMC article. Review.
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer.
Campone M, De Laurentiis M, Jhaveri K, Hu X, Ladoire S, Patsouris A, Zamagni C, Cui J, Cazzaniga M, Cil T, Jerzak KJ, Fuentes C, Yoshinami T, Rodriguez-Lescure A, Sezer A, Fontana A, Guarneri V, Molckovsky A, Mouret-Reynier MA, Demirci U, Zhang Y, Valota O, Lu DR, Martignoni M, Parameswaran J, Zhi X, Hamilton EP; VERITAC-2 Study Group. Campone M, et al. N Engl J Med. 2025 Aug 7;393(6):556-568. doi: 10.1056/NEJMoa2505725. Epub 2025 May 31. N Engl J Med. 2025. PMID: 40454645 Clinical Trial.
Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer.
Fizazi K, Chi KN, Shore ND, Herrmann K, de Bono JS, Castellano D, Piulats JM, Fléchon A, Wei XX, Mahammedi H, Roubaud G, Fleming M, Haas T, Ghebremariam S, Kreisl TN, Rajagopalan S, Sartor O, Morris MJ; PSMAfore Investigators. Fizazi K, et al. Ann Oncol. 2025 Jul 17:S0923-7534(25)00852-X. doi: 10.1016/j.annonc.2025.07.003. Online ahead of print. Ann Oncol. 2025. PMID: 40680993 Free PMC article.
Immunotherapy in Testicular Germ Cell Tumors.
Kalavska K, Schmidtova S, Chovanec M, Mego M. Kalavska K, et al. Among authors: mego m. Front Oncol. 2020 Sep 24;10:573977. doi: 10.3389/fonc.2020.573977. eCollection 2020. Front Oncol. 2020. PMID: 33072608 Free PMC article. Review.
Microbiome in Cancer Development and Treatment.
Ciernikova S, Sevcikova A, Mladosievicova B, Mego M. Ciernikova S, et al. Among authors: mego m. Microorganisms. 2023 Dec 22;12(1):24. doi: 10.3390/microorganisms12010024. Microorganisms. 2023. PMID: 38257851 Free PMC article. Review.
Overcoming Chemotherapy Resistance in Germ Cell Tumors.
Országhová Z, Kalavska K, Mego M, Chovanec M. Országhová Z, et al. Among authors: mego m. Biomedicines. 2022 Apr 22;10(5):972. doi: 10.3390/biomedicines10050972. Biomedicines. 2022. PMID: 35625709 Free PMC article. Review.
238 results